| Brittany Whitlock Hightower, AUD | |
|
2061 Peachtree Rd Ne Ste 300a, Atlanta, GA 30309-1447 | |
| (700) 422-2777 | |
| Not Available |
| Full Name | Brittany Whitlock Hightower |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 16 Years |
| Location | 2061 Peachtree Rd Ne Ste 300a, Atlanta, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972941581 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 003932 (Georgia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northwest Ent Associates Pc | 2264498807 | 16 |
News Archive
A strong, black coffee to wake you up after a bad night's sleep could impair control of blood sugar levels, according to a new study.
At the 64th ASMS Conference, Bruker introduces an entirely new mass spectrometry technology platform: the innovative timsTOF™ system combines very high ion mobility resolution greater than 200, using Bruker's proprietary Trapped Ion Mobility Spectrometry (TIMS), with Bruker's ultra-high performance ESI-QTOF mass spectrometry.
Takeda Pharmaceutical Company Limited ("Takeda") today announced that a Marketing Authorisation Application (MAA) has been submitted to The European Medicines Agency (EMA) for vedolizumab, an investigational, gut-selective humanized monoclonal antibody for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD), the two most common types of inflammatory bowel disease (IBD).
A team of University of Missouri neuroscientists are inching closer to developing the tools needed to decipher the brain.
› Verified 8 days ago
| Provider Name | Northwest Ent Associates Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1821176967 PECOS PAC ID: 2264498807 Enrollment ID: O20080521000553 |
News Archive
A strong, black coffee to wake you up after a bad night's sleep could impair control of blood sugar levels, according to a new study.
At the 64th ASMS Conference, Bruker introduces an entirely new mass spectrometry technology platform: the innovative timsTOF™ system combines very high ion mobility resolution greater than 200, using Bruker's proprietary Trapped Ion Mobility Spectrometry (TIMS), with Bruker's ultra-high performance ESI-QTOF mass spectrometry.
Takeda Pharmaceutical Company Limited ("Takeda") today announced that a Marketing Authorisation Application (MAA) has been submitted to The European Medicines Agency (EMA) for vedolizumab, an investigational, gut-selective humanized monoclonal antibody for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD), the two most common types of inflammatory bowel disease (IBD).
A team of University of Missouri neuroscientists are inching closer to developing the tools needed to decipher the brain.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brittany Whitlock Hightower, AUD 256 Eureka Dr Ne, Atlanta, GA 30305-4215 Ph: (770) 713-2708 | Brittany Whitlock Hightower, AUD 2061 Peachtree Rd Ne Ste 300a, Atlanta, GA 30309-1447 Ph: (700) 422-2777 |
News Archive
A strong, black coffee to wake you up after a bad night's sleep could impair control of blood sugar levels, according to a new study.
At the 64th ASMS Conference, Bruker introduces an entirely new mass spectrometry technology platform: the innovative timsTOF™ system combines very high ion mobility resolution greater than 200, using Bruker's proprietary Trapped Ion Mobility Spectrometry (TIMS), with Bruker's ultra-high performance ESI-QTOF mass spectrometry.
Takeda Pharmaceutical Company Limited ("Takeda") today announced that a Marketing Authorisation Application (MAA) has been submitted to The European Medicines Agency (EMA) for vedolizumab, an investigational, gut-selective humanized monoclonal antibody for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD), the two most common types of inflammatory bowel disease (IBD).
A team of University of Missouri neuroscientists are inching closer to developing the tools needed to decipher the brain.
› Verified 8 days ago
Buckhead Ear, Nose And Throat Audiologist Medicare: Medicare Enrolled Practice Location: 1800 Peachtree St Nw, Suite 700, Atlanta, GA 30309 Phone: 404-350-7966 Fax: 404-350-7968 | |
Dr. Debra Burnett Brewer, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1365 Clifton Rd Ne # A2334, Atlanta, GA 30322 Phone: 404-778-4441 Fax: 404-778-4295 | |
Beftu Teklu, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 5673 Peachtree Dunwoody Rd Ste 150, Atlanta, GA 30342 Phone: 404-297-1785 | |
Margaret Jane Butler, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 5461 Meridian Mark Rd Ste 130, Atlanta, GA 30342 Phone: 404-591-1884 | |
Patricia Beatriz Masso Maldonado, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 5881 Glenridge Dr Ste 230, Atlanta, GA 30328 Phone: 404-943-0170 | |
Mr. Alan I Segal, M.S. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 960 Johnson Ferry Rd Ne, Ste 200, Atlanta, GA 30342 Phone: 404-943-0900 | |
Kelly Clinkscales Calkins, AU.D Audiologist Medicare: Medicare Enrolled Practice Location: 550 Peachtree St Ne, Ste 1640, Atlanta, GA 30308 Phone: 404-653-0830 Fax: 404-653-0832 |